IDENTIFYING THE ANTIGENIC TARGET OF AUTOIMMUNE SENSORINEURAL HEARING LOSS (AISNHL) AND DEVELOPEMENT OF SPECIFIC TESTS FOR DIAGNOSIS AND MANAGEMENT OF AISNHL
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 5, 2001
app pub date -
Dec 29, 1998
filing date -
Dec 29, 1998
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The substantial purification and characterization of the glycoprotein Inner Ear Supporting Cell Antigen (IESCA) is described, along with methods employing IESCA to detect autoimmune sensorineural hearing loss (AISNHL), agonists and antagonists of IESCA binding and anti-IESCA binding, as well as homologs of IESCA.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully